news, Background
Milagros Flores
Kidney Week in Denver: Day 1

Day of Kidney Week 2026. The NephJC crew discusses 6 studies, including some blockbustr IgA news.

Kidney Week in Denver: Day 1
Background
Brian Rifkin
Can Dialysis Outshine Transplant in the Elderly?

This week, we will discuss whether decreased donor transplantation improves mortality in all patients. In this target trial emulation standard donor, extended donor, donation after brain death and donation after cardiac death outcomes are compared across age groups with different co-morbid conditions.

Can Dialysis Outshine Transplant in the Elderly?
Background
Brian Rifkin
Why Can’t I Quit You: Steroid Tapering in ...

This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).

Why Can’t I Quit You: Steroid Tapering in Adults with Podocytopathies (START)
Meta
joel topf
NephJC 2026 Fall Pledge Drive

Help keep NephJC a vital, original, and unbiased source of medical education.

NephJC 2026 Fall Pledge Drive
Background
Brian Rifkin
REFINe-ing AI’s Role in Nephrology Diagnosis

This week, we will discuss the use of LLMs for the diagnosis of complex nephrology cases. Can AI help nephrologists nail the correct diagnosis?

REFINe-ing AI’s Role in Nephrology Diagnosis

Background

The Roxadustat Chronicles: A Two-Article NephJC

The Roxadustat Chronicles: A Two-Article NephJC

The HIF inhibitor trials were announced almost a year and half ago at KidneyWk 2019. We are finally seeing the trials get published. Here are the first two, a sub-group analysis of three dialysis studies focused on incident dialysis patients and a placebo controlled pre-dialysis study.